Recent advances in treatment, particularly hybrid closed-loop systems, have substantially improved quality of life and reduced the incidence of insulin-related acute complications such as severe hypoglycemia, hyperglycemia, and ketoacidosis (6). The gene discussed is INS; the disease is Hypoglycemia.